Aptevo Therapeutics Files S-1/A Amendment
Ticker: APVO · Form: S-1/A · Filed: Mar 27, 2025 · CIK: 1671584
| Field | Detail |
|---|---|
| Company | Aptevo Therapeutics Inc. (APVO) |
| Form Type | S-1/A |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, registration, securities
Related Tickers: APVO
TL;DR
APVO filed an S-1/A amendment, looks like they're still working on their securities registration.
AI Summary
Aptevo Therapeutics Inc. filed an S-1/A amendment on March 27, 2025, for its registration statement. The filing, with SEC file number 333-285476, pertains to the company's securities and is governed by the Securities Act of 1933. Aptevo Therapeutics Inc. is incorporated in Delaware and its principal executive offices are located in Seattle, Washington.
Why It Matters
This S-1/A filing indicates ongoing regulatory activity for Aptevo Therapeutics Inc., potentially related to the issuance or sale of securities, which could impact its capital structure and future operations.
Risk Assessment
Risk Level: medium — S-1/A filings often relate to capital raising or significant corporate actions, which carry inherent risks for investors.
Key Numbers
- 333-285476 — SEC File Number (Identifies the specific registration filing with the SEC.)
- 20250327 — Filing Date (The date the amendment was filed with the SEC.)
Key Players & Entities
- Aptevo Therapeutics Inc. (company) — Registrant
- 333-285476 (dollar_amount) — SEC File Number
- 20250327 (dollar_amount) — Filing Date
- Marvin L. White (person) — President and Chief Executive Officer
FAQ
What is the purpose of this S-1/A filing?
This is an amendment to a registration statement (Form S-1) filed under the Securities Act of 1933, indicating ongoing efforts related to the registration of securities.
When was this amendment filed?
The amendment was filed on March 27, 2025.
What is the SEC file number for this registration?
The SEC file number is 333-285476.
Where is Aptevo Therapeutics Inc. headquartered?
Aptevo Therapeutics Inc.'s principal executive offices are located at 2401 4th Avenue, Suite 1050, Seattle, Washington, 98121.
Who is the President and CEO of Aptevo Therapeutics Inc. mentioned in the filing?
Marvin L. White is listed as the President and Chief Executive Officer.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on March 27, 2025 by Marvin L. White regarding Aptevo Therapeutics Inc. (APVO).